These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
172 related items for PubMed ID: 17306767
1. Histamine H3 and dopamine D2 receptor-mediated [35S]GTPgamma[S] binding in rat striatum: evidence for additive effects but lack of interactions. Humbert-Claude M, Morisset S, Gbahou F, Arrang JM. Biochem Pharmacol; 2007 Apr 15; 73(8):1172-81. PubMed ID: 17306767 [Abstract] [Full Text] [Related]
2. Histamine H3-receptor-mediated [35S]GTP gamma[S] binding: evidence for constitutive activity of the recombinant and native rat and human H3 receptors. Rouleau A, Ligneau X, Tardivel-Lacombe J, Morisset S, Gbahou F, Schwartz JC, Arrang JM. Br J Pharmacol; 2002 Jan 15; 135(2):383-92. PubMed ID: 11815373 [Abstract] [Full Text] [Related]
3. Dopamine D2 receptor-mediated G protein activation assessed by agonist-stimulated [35S]guanosine 5'-O-(gamma-thiotriphosphate) binding in rat striatal membranes. Odagaki Y, Toyoshima R. Prog Neuropsychopharmacol Biol Psychiatry; 2006 Sep 30; 30(7):1304-12. PubMed ID: 16824659 [Abstract] [Full Text] [Related]
4. Evidence for the coupling of Gq protein to D1-like dopamine sites in rat striatum: possible role in dopamine-mediated inositol phosphate formation. Wang HY, Undie AS, Friedman E. Mol Pharmacol; 1995 Dec 30; 48(6):988-94. PubMed ID: 8848015 [Abstract] [Full Text] [Related]
5. Pre-synaptic histamine H3 receptors regulate glutamate, but not GABA release in rat thalamus. Garduño-Torres B, Treviño M, Gutiérrez R, Arias-Montaño JA. Neuropharmacology; 2007 Feb 30; 52(2):527-35. PubMed ID: 17027043 [Abstract] [Full Text] [Related]
6. S32504, a novel naphtoxazine agonist at dopamine D3/D2 receptors: I. Cellular, electrophysiological, and neurochemical profile in comparison with ropinirole. Millan MJ, Cussac D, Gobert A, Lejeune F, Rivet JM, Mannoury La Cour C, Newman-Tancredi A, Peglion JL. J Pharmacol Exp Ther; 2004 Jun 30; 309(3):903-20. PubMed ID: 14978194 [Abstract] [Full Text] [Related]
9. In vitro characterization of SLV308 (7-[4-methyl-1-piperazinyl]-2(3H)-benzoxazolone, monohydrochloride): a novel partial dopamine D2 and D3 receptor agonist and serotonin 5-HT1A receptor agonist. Glennon JC, Van Scharrenburg G, Ronken E, Hesselink MB, Reinders JH, Van Der Neut M, Long SK, Feenstra RW, McCreary AC. Synapse; 2006 Dec 15; 60(8):599-608. PubMed ID: 17001660 [Abstract] [Full Text] [Related]
11. Synthesis and in vitro pharmacology of a series of new chiral histamine H3-receptor ligands: 2-(R and S)-Amino-3-(1H-imidazol-4(5)-yl)propyl ether derivatives. Kovalainen JT, Christiaans JA, Kotisaari S, Laitinen JT, Männistö PT, Tuomisto L, Gynther J. J Med Chem; 1999 Apr 08; 42(7):1193-202. PubMed ID: 10197963 [Abstract] [Full Text] [Related]